HP&M to Speak at Next Week’s FDLI Conference on the Drug Quality and Security Act, Titles I and II – A “Not-to-Miss Event!”

HP&M to Speak at Next Week’s FDLI Conference on the Drug Quality and Security Act, Titles I and II – A “Not-to-Miss Event!”

HP&M to Speak at Next Week’s FDLI Conference on the Drug Quality and Security Act, Titles I and II – A “Not-to-Miss Event!”

Posted: 26 Nov 2018 08:52 AM PST

By Hyman, Phelps & McNamara, P.C. —

On Tuesday December 4th, the Food & Drug Law Institute will hold a conference in Washington, D.C., on current issues surrounding implementation of Titles I (the Compounding Quality Act) and II (the Drug Supply Chain Security Act) of the Drug Quality and Security Act (DQSA). The Conference will include updates on implementation of the DQSA, and in-depth panel discussions addressing hot topics covering both the DSCSA and CQA.  FDA’s Dr. Julie Dohm (Senior Science Advisor for Compounding, CDER) will give the keynote address on the CQA, and FDA’s Illisa B.G. Bernstein (Deputy Director, Office of Compliance, CDER) will deliver the keynote address on the DSCSA.  Hyman, Phelps & McNamara, P.C.’s DQSA expert, Karla L. Palmer, who chaired the Conference last year, is one of the speakers at this year’s Conference.

Click here for a copy of the conference agenda and to register. FDA Law Blog readers can receive a discount off the Conference registration price. (Use promotion code “DQSASavings.”) We encourage people to register for and attend this informative, one-day conference.  Note that last years’ Conference was sold out, so sign up soon.